«The work on antibodies isolated from survivors of
filovirus infections, including Marburg and Ebola, was started by James Crowe's laboratory at Vanderbilt University together with our laboratory
about 3 years ago,» said virologist Alex Bukreyev, professor at UTMB and co-corresponding author.